Navigation Links
REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
Date:4/17/2008

SAN DIEGO, April 17 /PRNewswire/ -- BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central nervous system (CNS) diseases, announced today that it raised an additional $20 million in an extension of its Series B financing, bringing the total to $50 million. New investor, New Enterprise Associates (NEA), along with current investors and Alexandria Real Estate Equities, Inc. participated in the extension. Other investors that participated in the Series B included MedImmune Ventures, Bay City Capital, Oxford Bioscience Partners, Technology Partners, Pappas Ventures and NeuroVentures. The financing will be used to continue clinical development of BCI's product candidates including a Phase 2 trial with BCI-540, and to identify additional assets to further expand its pipeline.

As part of the financing extension, BCI announced the addition of Chuck Newhall, general partner and co-founder of NEA, to its Board of Directors. Prior to NEA, he was a Vice President at T. Rowe Price Associates. Before that, Mr. Newhall founded the Mid-Atlantic Venture Capital Association (MAVA) and currently serves as Chairman Emeritus. His board memberships include Bravo by ElderHealth, CoGenesys, Hospital Partners of America, Pharmos, Sensors for Medicine & Science, Supernus Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae Pharmaceuticals.

"Only weeks after closing our first round of the Series B financing, we are thrilled with the result of the second close and bringing in the support of NEA, another high-quality investor," said Jim Schoeneck, CEO of BCI. "Chuck's decades of experience in the industry will be a tremendous asset to the company as we build momentum in the clinic this year."

BCI recently initiated a Phase 2a clinical trial with its lead product candidate, BCI-540, for the treatment of depression. The Company in-l
'/>"/>

SOURCE BrainCells Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Revised: Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
2. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
3. BrainCells Inc. Expands Series B Financing to $50 Million
4. ATS Medical Expands Open Pivot Heart Valve Offerings
5. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
6. BioLife Solutions Expands Scientific Advisory Board
7. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
8. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
9. Pharsight Expands Strategic Consulting Services Team
10. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
11. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... CHESTERBROOK, Pa. , Sept. 29, 2014 /PRNewswire/ ... of the largest global pharmaceutical sourcing and distribution ... analysis on coffee consumption. This research was analyzed ... coffee consumption was associated with an increase in ... The study looked at population-level coffee consumption across ...
(Date:9/27/2014)... the peer-reviewed Journal of Animal Science concludes ... has no impact on the health or productivity of ... and field data sets, the article documents evidence that ... crops are comparable with those of animals fed non-GE ... feed crops have become an increasing component of livestock ...
(Date:9/27/2014)... Researchers from The University of Texas at Dallas have ... wearable computers with self-contained power sources or, more immediately, ... of heavy use. , This technology, published online in ... power of a single electron to control energy consumption ... modern electronic systems. , Researchers from the Erik Jonsson ...
(Date:9/26/2014)... , Sept. 26, 2014  MicroBiome Therapeutics ... results from a proof of concept study testing ... the tolerability of metformin, the first-line therapy for ... of metformin and active ingredients contained in the ... an effective, safe and inexpensive medication, is recommended ...
Breaking Biology Technology:Coffee Consumption May Increase Survival and Reduce Healthcare Costs 2Coffee Consumption May Increase Survival and Reduce Healthcare Costs 3New UT Dallas technology may lead to prolonged power in mobile devices 2New UT Dallas technology may lead to prolonged power in mobile devices 3Positive Proof Of Concept Study Shows MicroBiome Therapeutics' NM505 May Improve Tolerability Of Metformin In Type 2 Diabetes 2Positive Proof Of Concept Study Shows MicroBiome Therapeutics' NM505 May Improve Tolerability Of Metformin In Type 2 Diabetes 3
... Calif., May 6 Finesse Solutions, LLC,Santa ... control solutions for,life sciences process applications, announced ... of Software. Basil brings over 19 years ... a focus on,implementing high efficiency engineering, resource ...
... Award at Leading Venture Contest Makes Carnegie Mellon ,Winningest, ... ... time, a team of,students from the Tepper School of Business at Carnegie ... competition Moot,Corp(R). This year,s winning venture business -- NeuroBank -- has developed,a ...
... Md., May 6 PharmAthene, Inc.,(Amex: PIP ) ... threats, announced today that its financial results,for the first ... 13, 2008., PharmAthene management will be hosting a ... The call is scheduled to begin at,4:30 p.m. Eastern ...
Cached Biology Technology:Basil Zimmo Joins Finesse Solutions as Vice-President of Software 2Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition 2PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008 2
(Date:9/29/2014)... Monday, September 29: Between 1970 and 2010 populations ... the globe dropped 52 percent, says the 2014 ... Fund (WWF). This biodiversity loss occurs disproportionately in ... of high-income countries. , In addition to the ... point to other warning signs about the overall ...
(Date:9/29/2014)... Texas at Arlington research team says recently identified radiation ... lab could open doors for homeland security and medical ... the Oct. 1 issue of Optics Letters , ... describe a new method to fabricate transparent nanoscintillators by ... a transparent ceramic is formed. A scintillator refers ...
(Date:9/29/2014)... received a five-year, $6 million grant for clinical ... and development of safe and effective treatments for ... the National Institutes of Health, National Institute on ... Medication Development for Cocaine Use Disorder to oversee ... decisions on moving forward with more expensive large-scale ...
Breaking Biology News(10 mins):Half of global wildlife lost, says new WWF report 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3New VCU center to target cocaine addiction 2
... of a tiny shrimp-like species, known scientifically as ... non-native quagga mussels in the Great Lakes, say NOAA ... Diporeia and many aquatic species have steadily ... NOAA,s Great Lakes Environmental Laboratory published,this week in ...
... University have developed a new tool that makes it possible ... generation of blood vessels. The researchers, findings, published in ... enable scientists to determine what signals in the body attract ... tumor research. The new invention is a tiny cell ...
... a startling result, a new study published by the ... than 80 percent of the world,s major armed conflicts ... biologically diverse and threatened places on Earth. Titled ... conservation scientists compared major conflict zones with the Earth,s ...
Cached Biology News:Tiny tool to control growing blood vessels opens new potential in tumor research 2Study finds most wars occur in Earth's richest biological regions 2Study finds most wars occur in Earth's richest biological regions 3
Preparation TW--Compatibility: Push-on end cap seals suitable up to 70 C only -Hybridization Tube for Model HB-1D -Comp Dim: 200 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-12...
Preparation TW--Compatibility: no end cap seals -Hybridization Tube for Hybrigene -Comp Dim: 240 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-15...
...
... in hybridization incubators with rotators. Graduated, ... size PP plug-seal screw-cap with O-ring ... three lengths to accept different size ... O-rings available separately. • Comp Dim: ...
Biology Products: